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Résumé en
anglais
Obstructive sleep apnea (OSA) is characterized by repetitive apnea-hypopnea cycles
during sleep associated with oxygen desaturation and sleep disruption. We evaluated
the role of circulating microparticles (MPs) from patients with OSA in the regulation
of vascular function. MPs from whole blood from patients with OSA or control
subjects were injected i.v. into mice. Injection of MPs from patients with OSA
induced ex vivo vascular hyperreactivity in aortas with functional endothelium but,
in contrast, hyporeactivity in vessels without functional endothelium. Vascular
hyperreactivity was blunted in the presence of a nitric oxide synthase inhibitor alone
or combined with the cyclooxygenase inhibitor indomethacin. MPs from patients
with OSA reduced endothelial nitric oxide synthase activity and nitric oxide
production, increased aortic cyclooxygenase-1 and cyclooxygenase-2 expression, and
increased thromboxane A(2) and prostacyclin production. Blockade of thromboxane
A(2) receptor did not affect the serotonin response in arteries from OSA MP-treated
mice. A superoxide dismutase mimetic reduced the vascular hyperreactivity induced
by MPs from patients with OSA but had no effect on contraction in vessels from
control and non-OSA MP-treated mice. These data provide evidence that circulating
MPs from patients with OSA induce ex vivo vascular hyperreactivity with the
obligatory role of the endothelium and subtle interactions between the nitric oxide
and cyclooxygenase pathways and metabolites. These results highlight the
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